December 13, 2016
GSK substitutes Pricewaterhouse with Delloite
GSK has announced on Tuesday that it intends to appoint Deloitte LLP (“Deloitte”) as its auditor with effect from the…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
December 13, 2016
Pharnext: New approach in the treatment of Alzheimer’s disease
A French biopharmaceutical company focused on neurodegenerative diseases Pharnext, said that testing of a Pleodrug being developed for the treatment of…
December 13, 2016
FDA grants priority review status for AstraZeneca’s bladder cancer drug durvalumab
AstraZeneca’s application (BLA) for durvalumab for BLA in bladder cancer was accepted by the FDA. The PD-L1 human monoclonal antibody…
December 13, 2016
OptiBiotix’s SlimBiome technology for food and OTC products in Asian market
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
December 13, 2016
4D pharma’s Blautix for Irritable Bowel Syndrome shows positive impact
4D Pharma’s Blautix, a single strain live biotherapeutic for the treatment of chronic abdomen disorder, Irritable Bowel Syndrome (IBS), has…
December 13, 2016
Eli Lilly announces dividend increase
The board of directors of Eli Lilly has announced a 2 percent increase in its quarterly dividend. The dividend for…
December 13, 2016
Monsanto shareowners approve merger with Bayer
Shareowners of the Monsanto Company have approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft.
December 13, 2016
Zealand Pharma increases share capital
Zealand Pharma has on Monday increased its share capital with nominal DKK 13,999 divided into 13,999 new shares with a…
December 13, 2016
Short: Active Biotech completes issuing rights, share capital up by €2,7M
The results of Active Biotech’s rights issue show that 6,643,426 shares, which is about 96 percent of the shares offered,…
December 13, 2016
Type 2 diabetes gets new treatment in U.S., FDA OKs Boehringer’s Synjardy XR
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Synjardy XR tablets for adults with type 2 diabetes.…